NASDAQ · CAH
Healthcare · Medical - Distribution
$225.38
Down-$0.96 (-0.42%)
Updated Sep 20, 2026, 12:06 PM
SID Score
6.1/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 19 trading sessions · Daily adjusted prices
CAH closed at $225.38 after 19 trading sessions, down 3.01% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $225.29 | $226.1197 | $221.6974 | $225.38 | 4.14M |
| Sep 17, 2026 | $232.71 | $232.71 | $226.02 | $226.34 | 2.26M |
| Sep 16, 2026 | $233.07 | $234.90 | $232.09 | $232.54 | 1.22M |
| Sep 15, 2026 | $233.89 | $234.83 | $230.34 | $232.65 | 1.8M |
| Sep 14, 2026 | $236.76 | $237.565 | $232.60 | $234.89 | 2.17M |
| Sep 11, 2026 | $238.77 | $239.43 | $232.60 | $234.57 | 1.11M |
| Sep 10, 2026 | $241.27 | $242.12 | $235.67 | $236.02 | 1.22M |
| Sep 9, 2026 | $239.02 | $241.64 | $238.405 | $240.00 | 1.03M |
| Sep 8, 2026 | $243.90 | $245.83 | $239.425 | $240.49 | 1.6M |
| Sep 4, 2026 | $246.34 | $249.29 | $246.29 | $247.18 | 1.55M |
| Sep 3, 2026 | $246.11 | $249.26 | $245.82 | $248.61 | 1.39M |
| Sep 2, 2026 | $240.99 | $246.02 | $239.35 | $245.49 | 1.36M |
| Sep 1, 2026 | $236.85 | $240.75 | $236.025 | $239.35 | 1.34M |
| Aug 31, 2026 | $234.92 | $236.97 | $233.51 | $234.62 | 1.67M |
| Aug 28, 2026 | $236.02 | $236.80 | $233.72 | $234.55 | 1.78M |
| Aug 27, 2026 | $236.49 | $237.30 | $234.15 | $235.13 | 1.03M |
| Aug 26, 2026 | $237.90 | $240.88 | $236.445 | $238.40 | 1.47M |
| Aug 25, 2026 | $232.51 | $238.10 | $232.375 | $237.92 | 1.34M |
| Aug 24, 2026 | $229.16 | $232.37 | $227.68 | $232.37 | 1.4M |
The latest Smart Investors Daily articles mentioning CAH.
CAH research
Company profile and research snapshot.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | RBC Capital | Outperform | — |
| Aug 13, 2026 | JP Morgan | Neutral | — |
| Aug 13, 2026 | TD Cowen | Buy | — |
| Aug 13, 2026 | Barclays | Overweight | — |
| Aug 12, 2026 | Morgan Stanley | Overweight | — |
No generated briefing is available yet.
Yahoo · Sep 16, 2026
Cardinal Health has outperformed the Health Care Services industry over the past year, and analysts are highly optimistic about the stock’s prospects.
Yahoo · Sep 15, 2026
The latest trading day saw Cardinal Health (CAH) settling at $232.36, representing a -1.08% change from its previous close.
SeekingAlpha · Sep 15, 2026
Cardinal Health, Inc. (CAH) 2026 Global Healthcare Conference September 15, 2026 9:05 AM EDTCompany ParticipantsDavid Frost - Vice President of Investor...
Yahoo · Sep 14, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CAH.
